Laserfiche WebLink
f. Co -responder and/or alternative responder models to address OUD-related 911 calls with <br />greater SUD expertise <br />2. Support pre-trial services that connect individuals with OUD and any co-occurring SUD/MH <br />conditions to evidence -informed treatment, including MAT, and related services. <br />3. Support treatment and recovery courts that provide evidence -based options for persons with OUD <br />and any co-occurring SUD/MH conditions <br />4. Provide evidence -informed treatment, including MAT, recovery support, harm reduction, or other <br />appropriate services to individuals with OUD and any co-occurring SUD/MH conditions who are <br />incarcerated in jail or prison. <br />5. Provide evidence -informed treatment, including MAT, recovery support, harm reduction, or other <br />appropriate services to individuals with OUD and any co-occurring SUD/MH conditions who are <br />leaving jail or prison have recently left jail or prison, are on probation or parole, are under community <br />corrections supervision, or are in re-entry programs or facilities. <br />6. Support critical time interventions (CTI), particularly for individuals living with dual -diagnosis <br />OUD/serious mental illness, and services for individuals who face immediate risks and service needs <br />and risks upon release from correctional settings. <br />7. Provide training on best practices for addressing the needs of criminal -justice -involved persons with <br />OUD and any co-occurring SUD/MH conditions to law enforcement, correctional, or judicial personnel <br />or to providers of treatment, recovery, harm reduction, case management, or other services offered in <br />connection with any of the strategies described in this section. <br />E. ADDRESS THE NEEDS OF PREGNANT OR PARENTING WOMEN AND THEIR <br />FAMILIES, INCLUDING BABIES WITH NEONATAL ABSTINENCE SYNDROME <br />Address the needs of pregnant or parenting women with OUD and any co-occurring SUD/MH <br />conditions, and the needs of their families, including babies with neonatal abstinence syndrome (NAS), <br />through evidence -based or evidence -informed programs or strategies that may include, but are not <br />limited to, the following: <br />1. Support evidence -based or evidence -informed treatment, including MAT, recovery services and <br />supports, and prevention services for pregnant women — or women who could become pregnant — who <br />have OUD and any co-occurring SUD/MH conditions, and other measures to educate and provide <br />support to families affected by Neonatal Abstinence Syndrome. <br />2. Expand comprehensive evidence -based treatment and recovery services, including MAT, for <br />uninsured women with OUD and any co-occurring SUD/MH conditions for up to 12 months <br />postpartum. <br />3. Training for obstetricians or other healthcare personnel that work with pregnant women and their <br />families regarding treatment of OUD and any co-occurring SUD/MH conditions. <br />4. Expand comprehensive evidence -based treatment and recovery support for NAS babies; expand <br />services for better continuum of care with infant -need dyad; expand long-term treatment and services <br />for medical monitoring of NAS babies and their families. <br />74 <br />